Douglas Carr - Net Worth and Insider Trading

Douglas Carr Net Worth

The estimated net worth of Douglas Carr is at least $874,310 dollars as of 2024-04-27. Douglas Carr is the SVP Finance & Operations of Century Therapeutics Inc and owns about 303,580 shares of Century Therapeutics Inc (IPSC) stock worth over $874,310. Details can be seen in Douglas Carr's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Douglas Carr has not made any transactions after 2024-02-06 and currently still holds the listed stock(s).

Transaction Summary of Douglas Carr

To

Douglas Carr Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Douglas Carr owns 1 companies in total, including Century Therapeutics Inc (IPSC) .

Click here to see the complete history of Douglas Carr’s form 4 insider trades.

Insider Ownership Summary of Douglas Carr

Ticker Comapny Transaction Date Type of Owner
IPSC Century Therapeutics Inc 2024-02-06 VP of Finance and Operations

Douglas Carr Latest Holdings Summary

Douglas Carr currently owns a total of 1 stock. Douglas Carr owns 303,580 shares of Century Therapeutics Inc (IPSC) as of February 6, 2024, with a value of $874,310.

Latest Holdings of Douglas Carr

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
IPSC Century Therapeutics Inc 2024-02-06 303,580 2.88 874,310

Holding Weightings of Douglas Carr


Douglas Carr Form 4 Trading Tracker

According to the SEC Form 4 filings, Douglas Carr has made a total of 1 transactions in Century Therapeutics Inc (IPSC) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Century Therapeutics Inc is the sale of 1,200 shares on February 6, 2024, which brought Douglas Carr around $4,968.

Insider Trading History of Douglas Carr

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Douglas Carr Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Douglas Carr Ownership Network

Ownership Network List of Douglas Carr

No Data

Ownership Network Relation of Douglas Carr


Douglas Carr Owned Company Details

What does Century Therapeutics Inc do?

Who are the key executives at Century Therapeutics Inc?

Douglas Carr is the VP of Finance and Operations of Century Therapeutics Inc. Other key executives at Century Therapeutics Inc include Chief Technology Officer Gregory Russotti , Chief Operations Officer Adrienne Farid , and Chief Scientific Officer Luis Borges .

Century Therapeutics Inc (IPSC) Insider Trades Summary

Over the past 18 months, Douglas Carr made 1 insider transaction in Century Therapeutics Inc (IPSC) with a net sale of 1,200. Other recent insider transactions involving Century Therapeutics Inc (IPSC) include a net sale of 57,819 shares made by Adrienne Farid , a net sale of 144,911 shares made by Luis Borges , and a net sale of 5,000 shares made by Gregory Russotti .

In summary, during the past 3 months, insiders sold 64,019 shares of Century Therapeutics Inc (IPSC) in total and bought 0 shares, with a net sale of 64,019 shares. During the past 18 months, 208,930 shares of Century Therapeutics Inc (IPSC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 208,930 shares.

Century Therapeutics Inc (IPSC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Century Therapeutics Inc Insider Transactions

No Available Data

Douglas Carr Mailing Address

Above is the net worth, insider trading, and ownership report for Douglas Carr. You might contact Douglas Carr via mailing address: C/o Century Therapeutics, Inc., 3675 Market Street, Philadelphia Pa 19104.

Discussions on Douglas Carr

No discussions yet.